539206
GVBL
Start SIP
Invest Now
Start SIP in GVBL
Performance
- Low
- ₹24
- High
- ₹27
- 52 Week Low
- ₹20
- 52 Week High
- ₹71
- Open Price₹27
- Previous Close₹26
- Volume190
- 50 DMA₹26.02
- 100 DMA₹29.86
- 200 DMA₹37.45
Investment Returns
- Over 1 Month -7.12%
- Over 3 Month -22.54%
- Over 6 Month -50.61%
- Over 1 Year -44.14%
Smart Investing Starts Here Start SIP with Genomic Valley Biotech for Steady Growth!
Genomic Valley Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -163.3
- PEG Ratio
- 1.5
- Market Cap Cr
- 7
- P/B Ratio
- 1.9
- Average True Range
- 2.69
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.05
- RSI
- 44.21
- MFI
- 66.51
Genomic Valley Biotech Financials
Genomic Valley Biotech Technicals
EMA & SMA
Current Price
₹24.02
-1.98
(-7.62%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹25.02
- 50 Day
- ₹26.02
- 100 Day
- ₹29.86
- 200 Day
- ₹37.45
Resistance and Support
25.01
- R3 28.99
- R2 27.99
- R1 26.01
- S1 23.03
- S2 22.03
- S3 20.05
Genomic Valley Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-15 | Quarterly Results | |
| 2025-10-15 | Quarterly Results | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Genomic Valley Biotech F&O
About Genomic Valley Biotech
- NSE Symbol
- GVBL
- BSE Symbol
- 539206
- Managing Director
- Mr. Yogesh Agrawal
- ISIN
- INE574D01010
Similar Stocks to Genomic Valley Biotech
Genomic Valley Biotech FAQs
Genomic Valley Biotech share price is ₹24 As on 07 February, 2026 | 11:27
The Market Cap of Genomic Valley Biotech is ₹7.3 Cr As on 07 February, 2026 | 11:27
The P/E ratio of Genomic Valley Biotech is -163.3 As on 07 February, 2026 | 11:27
The PB ratio of Genomic Valley Biotech is 1.9 As on 07 February, 2026 | 11:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.